Ultragenyx Pharmaceutical
Balance Sheet
Last updated:
The balance sheet is a financial statement presenting the value of assets, liabilities and equity of a company. How has Ultragenyx Pharmaceutical's balance sheet done over the years? Its assets were worth $1,491,013,000 last year, which is less than in the previous period. 82% of Ultragenyx Pharmaceutical’s total assets is currently financed by debt. Its liabilities reached the amount of $1,215,599,000, which means an increase by 2% compared compared to last year.
Debt to Assets
| 2014 | 197967000 | 13.02M | 6.58% |
|---|---|---|---|
| 2015 | 559569000 | 28.47M | 5.09% |
| 2016 | 540626000 | 66.65M | 12.33% |
| 2017 | 490753000 | 107.29M | 21.86% |
| 2018 | 719558000 | 110.65M | 15.38% |
| 2019 | 1135496000 | 481.73M | 42.42% |
| 2020 | 1759555000 | 605.18M | 34.39% |
| 2021 | 1522397000 | 599.83M | 39.4% |
| 2022 | 1545444000 | 1.19B | 77.19% |
| 2023 | 1491013000 | 1.21B | 81.53% |
RARE Balance Sheet (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Assets | ||||||||||
Current assets: | ||||||||||
Cash and cash equivalents | 213.58M | 132.94M | 307.58M | 713.52M | 433.58M | 113.43M | 100.48M | 161.12M | 93.56M | 24.32M |
Short term investments | 363.62M | 614.81M | 432.61M | 488.00M | 321.64M | 346.27M | 134.00M | 219.02M | 343.42M | 163.16M |
Net receivables | 73.39M | 40.44M | 28.43M | 23.09M | 32.84M | 12.74M | 5.17M | 0 | 0 | 0 |
Inventory | 33.96M | 26.76M | 16.23M | 13.04M | 11.54M | 7.06M | 757K | 0 | 0 | 0 |
Other current assets | 47.61M | 68.92M | -187.18M | 47.12M | 46.22M | 42.85M | 29.16M | 21.54M | 13.21M | 11.85M |
Total current assets | 732.18M | 883.89M | 856.60M | 1.29B | 851.01M | 522.36M | 244.46M | 498.11M | 450.20M | 187.48M |
Non-current assets: | ||||||||||
Property, Plant and Equipment | 290.56M | 285.68M | 176.18M | 114.03M | 74.67M | 20.04M | 21.83M | 17.05M | 7.37M | 3.03M |
Goodwill | 44.40M | 44.40M | 44.40M | 44.40M | 44.40M | 44.40M | 44.40M | 0 | 0 | 0 |
Intangible assets | 166.27M | 160.10M | 130.78M | 131.11M | 129M | 129.22M | 141.54M | 0 | 0 | 0 |
Long term investments | 199.90M | 154.50M | 293.85M | 165.88M | 32.92M | 0 | 9.97M | 117.96M | 99.25M | 0 |
Other non-current assets | 57.68M | 10.70M | 11.61M | -24.53M | -4.19M | 3.51M | 3.40M | -92.50M | 2.73M | 7.44M |
Total non-current assets | 758.82M | 661.54M | 665.79M | 464.25M | 284.47M | 197.18M | 246.28M | 42.51M | 109.36M | 10.48M |
Total assets | 1.49B | 1.54B | 1.52B | 1.75B | 1.13B | 719.55M | 490.75M | 540.62M | 559.56M | 197.96M |
Liabilities | ||||||||||
| Current liabilities: | ||||||||||
Accounts payable | ||||||||||
Deferred revenue | 0 | 1.47M | 7.60M | 59.21M | 0 | 0 | 5.98M | 0 | 0 | 0 |
Short term debt | 12.59M | 11.77M | 11.06M | 8.97M | 7.23M | 0 | 0 | 0 | 0 | 0 |
Total current liabilities | 280.43M | 261.21M | 181.36M | 189.60M | 103.3M | 74.72M | 71.01M | 60.25M | 27.91M | 12.51M |
| Non-current liabilities: | ||||||||||
Long term debt | 30.57M | 19.81M | 30.90M | 39.25M | 29.75M | 0 | 0 | 0 | 0 | 0 |
Deferred tax | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Other non-current liabilities | 874.53M | 880.25M | 352.79M | 335.66M | 315.36M | 4.75M | 5.11M | 6.39M | 561K | 505K |
Total non-current liabilities | 935.16M | 931.74M | 418.46M | 415.57M | 378.43M | 35.92M | 36.28M | 6.39M | 561K | 505K |
Total liabilities | 1.21B | 1.19B | 599.83M | 605.18M | 481.73M | 110.65M | 107.29M | 66.65M | 28.47M | 13.02M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |